tradingkey.logo

ICON PLC

ICLR
163.440USD
-0.350-0.21%
Cierre 09/29, 16:00ETCotizaciones retrasadas 15 min
12.71BCap. mercado
16.00P/E TTM

Más Datos de ICON PLC Compañía

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Información de ICON PLC

Símbolo de cotizaciónICLR
Nombre de la empresaICON PLC
Fecha de salida a bolsaMay 15, 1998
Director ejecutivoDr. Stephen (Steve) Cutler, Ph.D.
Número de empleados41900
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
DirecciónSouth County Business Park
CiudadDUBLIN
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIreland
Código postal- -
Teléfono35312912000
Sitio Webhttps://www.iconplc.com/
Símbolo de cotizaciónICLR
Fecha de salida a bolsaMay 15, 1998
Director ejecutivoDr. Stephen (Steve) Cutler, Ph.D.

Ejecutivos de ICON PLC

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Executive Officer, Chief Operating Officer
Chief Executive Officer, Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Ireland
722.90M
36.12%
United States
671.73M
33.56%
Rest of Europe
374.01M
18.69%
Rest of the World
232.69M
11.63%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Artisan Partners Limited Partnership
9.24%
Wellington Management Company, LLP
4.71%
MFS Investment Management
4.40%
Ninety One UK Limited
3.85%
Invesco Advisers, Inc.
3.25%
Otro
74.55%
Accionistas
Accionistas
Proporción
Artisan Partners Limited Partnership
9.24%
Wellington Management Company, LLP
4.71%
MFS Investment Management
4.40%
Ninety One UK Limited
3.85%
Invesco Advisers, Inc.
3.25%
Otro
74.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
41.49%
Investment Advisor
38.58%
Hedge Fund
14.95%
Research Firm
3.07%
Pension Fund
2.13%
Sovereign Wealth Fund
1.40%
Family Office
1.09%
Family Office
1.09%
Bank and Trust
0.88%

Participación institucional

Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1335
74.28M
95.51%
-11.33M
2025Q1
1362
81.04M
101.97%
-5.18M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
2023Q1
1190
81.67M
99.73%
-2.49M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Artisan Partners Limited Partnership
4.29M
5.4%
+4.10M
+2097.19%
Mar 31, 2025
Wellington Management Company, LLP
3.69M
4.65%
+1.58M
+74.76%
Mar 31, 2025
MFS Investment Management
2.83M
3.56%
-61.65K
-2.13%
Mar 31, 2025
Ninety One UK Limited
2.92M
3.67%
-28.77K
-0.98%
Mar 31, 2025
Invesco Advisers, Inc.
2.48M
3.12%
+1.10M
+79.31%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.66M
2.09%
+545.53K
+48.87%
Mar 31, 2025
Ruane, Cunniff & Goldfarb L.P.
1.25M
1.58%
-11.19K
-0.88%
Mar 31, 2025
Templeton Investment Counsel, L.L.C.
1.81M
2.28%
-69.99K
-3.72%
Mar 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares MSCI Ireland ETF
4.73%
Polen Capital International Growth ETF
4.14%
VanEck Biotech ETF
3.21%
Harbor Health Care ETF
2.27%
Polen Capital Global Growth ETF
2.22%
Distillate Small/Mid Cash Flow ETF
1.61%
Running Oak Efficient Growth ETF
1.52%
FPA Global Equity ETF
1.5%
Janus Henderson US Sustainable Equity ETF
1.37%
Motley Fool Global Opportunities ETF
1.33%
Ver más
iShares MSCI Ireland ETF
Proporción4.73%
Polen Capital International Growth ETF
Proporción4.14%
VanEck Biotech ETF
Proporción3.21%
Harbor Health Care ETF
Proporción2.27%
Polen Capital Global Growth ETF
Proporción2.22%
Distillate Small/Mid Cash Flow ETF
Proporción1.61%
Running Oak Efficient Growth ETF
Proporción1.52%
FPA Global Equity ETF
Proporción1.5%
Janus Henderson US Sustainable Equity ETF
Proporción1.37%
Motley Fool Global Opportunities ETF
Proporción1.33%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI